Amedeo Smart

Free Medical Literature Service



Liver Diseases

  Free Subscription

Articles published in
    October 2022
    Needle-free Nonalcoholic Fatty Liver Disease Prognostication: Moving One Step Closer.
    Gastroenterology. 2022;163:819-822.
    >> Share

  2. AJMERA V, Kim BK, Yang K, Majzoub AM, et al
    Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.
    Gastroenterology. 2022;163:1079-1089.
    >> Share

  3. SHINGINA A, Sarkar M, Feld L
    On the Importance of Safe Access to Reproductive Options for Adolescents and Women With Liver Disease.
    Gastroenterology. 2022;163:792-794.
    >> Share

  4. BAJAJ JS, Nagy LE
    Natural History of Alcohol-Associated Liver Disease: Understanding the Changing Landscape of Pathophysiology and Patient Care.
    Gastroenterology. 2022;163:840-851.
    >> Share

    September 2022
  5. DARA L
    No Necroptosis in Hepatocytes: The Final Nail in the Coffin?
    Gastroenterology. 2022 Sep 22. pii: S0016-5085(22)01083.
    >> Share

  6. HABER PK, Castet F, Torres-Martin M, Andreu-Oller C, et al
    Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma.
    Gastroenterology. 2022 Sep 12. pii: S0016-5085(22)01039.
    >> Share

  7. LONG MT, Noureddin M, Lim JK
    AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review.
    Gastroenterology. 2022;163:764-774.
    >> Share

  8. LEE BP, Terrault NA
    Advocacy for Equity in Transplantation Access for Alcohol-Associated Liver Disease: How Research Changed Medi-Cal Policy.
    Gastroenterology. 2022;163:539-542.
    >> Share

    August 2022
  9. PRESTON SP, Stutz MD, Allison CC, Nachbur U, et al
    Epigenetic silencing of RIPK3 in hepatocytes prevents MLKL-mediated necroptosis from contributing to liver pathologies.
    Gastroenterology. 2022 Aug 26. pii: S0016-5085(22)01021.
    >> Share

  10. LIU J, Feng G
    A 41-year-old man with an abdominal mass and hepatomegaly.
    Gastroenterology. 2022 Aug 17. pii: S0016-5085(22)00957.
    >> Share

  11. D'ALESSIO A, Pinato DJ
    Dissecting the tumour microenvironment to predict immunotherapy response in hepatocellular cancer.
    Gastroenterology. 2022 Aug 11. pii: S0016-5085(22)00950.
    >> Share

    Targeting de novo lipogenesis by different approaches shows promise in non-alcoholic steatohepatitis.
    Gastroenterology. 2022 Aug 10. pii: S0016-5085(22)00915.
    >> Share

  13. CLIFFORD C, Ryan R, Houlihan D
    An interesting case of hepatomegaly.
    Gastroenterology. 2022 Aug 10. pii: S0016-5085(22)00945.
    >> Share

  14. LO GH
    The beauty and sorrow of using PPI in patients with cirrhosis.
    Gastroenterology. 2022 Aug 3. pii: S0016-5085(22)00892.
    >> Share

    Further Insights Into the Impact of Bariatric Surgery on the Progression of Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2022;163:528-529.
    >> Share

  16. LE COSQUER G, Brunac AC, Peron JM
    An Unusual Case of Budd-Chiari Syndrome: Diagnosis and Treatment.
    Gastroenterology. 2022;163:e4-e5.
    >> Share

    July 2022
  17. BENHAMMOU JN, Rich NE, Cholankeril G, Zhang P, et al
    DETECT: Development of Technologies for Early HCC Detection.
    Gastroenterology. 2022;163:21-27.
    >> Share

  18. JAN J, Osho A, Murphy CC, Mazure CM, et al
    Gender, Age, Racial and Ethnic Disparities in Clinical Trial Enrollment for Primary Liver Cancer.
    Gastroenterology. 2022;163:14-20.
    >> Share

  19. TERRAULT NA, Williamson C
    Pregnancy-Associated Liver Diseases.
    Gastroenterology. 2022;163:97-117.
    >> Share

  20. KARACHALIOU GS, Shi C, Abdelmalek MF
    Liver Mass: Thinking Out of the Box.
    Gastroenterology. 2022;163:e10-e12.
    >> Share

    June 2022
  21. KIM NJ, Vutien P, Berry K, Ioannou GN, et al
    Hepatocellular carcinoma risk declines but remains high enough for screening in the first 7 years after HCV cure with DAAs in patients with cirrhosis or high FIB-4.
    Gastroenterology. 2022 Jun 28. pii: S0016-5085(22)00681.
    >> Share

  22. YING X, Rosenblatt R, Fortune BE
    Trends in Industry Payments to Gastroenterologists and Hepatologists in the United States from 2014 to 2020.
    Gastroenterology. 2022 Jun 14. pii: S0016-5085(22)00647.
    >> Share

  23. DUURSMA SS, Verkade HJ, Bodewes FAJA
    Cirrhosis and portal hypertension in compound heterozygous people with CF harboring one F508del CFTR gene mutation.
    Gastroenterology. 2022 Jun 10. pii: S0016-5085(22)00624.
    >> Share

  24. BAUER KC, Littlejohn PT, Ayala V, Creus-Cuadros A, et al
    Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective.
    Gastroenterology. 2022;162:1858-1875.
    >> Share

  25. SULLIVAN S, Jirapinyo P, Kumbhari V
    Clinical Care Pathway for the Risk Stratification and Management of Patients With Non-alcoholic Fatty Liver Disease.
    Gastroenterology. 2022;162:2131-2132.
    >> Share

    May 2022
  26. WANG J, Liu D, Chen S
    Proton Pump Inhibitors for Patients with Cirrhosis: Good Medicine or Poison?
    Gastroenterology. 2022 May 17. pii: S0016-5085(22)00514.
    >> Share

  27. NATSUI K, Maruyama M, Terai S
    Intrahepatic bile duct foreign body with cholangitis after pylorus preserving pancreatoduodenectomy: Is it a fish bone?
    Gastroenterology. 2022 May 14. pii: S0016-5085(22)00507.
    >> Share

  28. HU S, Molina L, Tao J, Liu S, et al
    NOTCH-YAP1/TEAD-DNMT1 axis drives hepatocyte reprogramming into intrahepatic cholangiocarcinoma.
    Gastroenterology. 2022 May 9. pii: S0016-5085(22)00477.
    >> Share

  29. SINGH SP
    Proton pump inhibitor increasing the risk of infection and mortality in cirrhosis- need closer look!
    Gastroenterology. 2022 May 2. pii: S0016-5085(22)00458.
    >> Share

  30. DONNELLY MC, Stableforth W, Krag A, Reuben A, et al
    The Negative Bidirectional Interaction Between Climate Change and the Prevalence and Care of Liver Disease: A Joint BSG, BASL, EASL, and AASLD Commentary.
    Gastroenterology. 2022;162:1561-1567.
    >> Share

  31. GOUDSMIT BFJ, Putter H, Van Hoek B
    The Model for End-Stage Liver Disease 3.0: An Update Without Proven Accuracy.
    Gastroenterology. 2022;162:1781-1782.
    >> Share

  32. GAN W, Liao B, Li X
    A Rare Cause of Liver Fibrosis in Adulthood.
    Gastroenterology. 2022;162:e1-e3.
    >> Share

    April 2022
    Effects of PPIs in cirrhotic patients: What do we really know?
    Gastroenterology. 2022 Apr 29. pii: S0016-5085(22)00452.
    >> Share

  34. COPPS KD, Tao R
    A role for hepatic insulin signaling in alpha1-antitrypsin deficiency.
    Gastroenterology. 2022 Apr 29. pii: S0016-5085(22)00457.
    >> Share

  35. MAHMUD N, Serper M, Taddei TH, Kaplan DE, et al
    The Association between Proton Pump Inhibitor Exposure and Key Liver-Related Outcomes in Patients with Cirrhosis: A Veterans Affairs Cohort Study.
    Gastroenterology. 2022 Apr 6. pii: S0016-5085(22)00352.
    >> Share

  36. YANG Y, Ju C
    Sulfation in Acetaminophen-Induced Liver Injury: Friend or Foe?
    Gastroenterology. 2022;162:1035-1037.
    >> Share

  37. XU P, Xi Y, Wang P, Luka Z, et al
    Inhibition of p53 Sulfoconjugation Prevents Oxidative Hepatotoxicity and Acute Liver Failure.
    Gastroenterology. 2022;162:1226-1241.
    >> Share

  38. QIAN T, Fujiwara N, Koneru B, Ono A, et al
    Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development.
    Gastroenterology. 2022;162:1210-1225.
    >> Share

    March 2022
  39. RUDNICK DA, Huang J, Hidvegi T, Chu AS, et al
    Regulation of PGC1alpha downstream of the insulin signaling pathway plays a role in the hepatic proteotoxicity of mutant alpha1-antitrypsin deficiency variant Z.
    Gastroenterology. 2022 Mar 14. pii: S0016-5085(22)00261.
    >> Share

  40. VELENOSI TJ, Ben-Yakov G, Podszun MC, Hercun J, et al
    Postprandial plasma lipidomics reveal specific alteration of hepatic-derived diacylglycerols in non-alcoholic fatty liver disease.
    Gastroenterology. 2022 Mar 10. pii: S0016-5085(22)00235.
    >> Share

  41. ALTAYAR O, Shah R, Chang CY, Falck-Ytter Y, et al
    AGA Technical Review on Systemic Therapies for Hepatocellular Carcinoma.
    Gastroenterology. 2022;162:937-951.
    >> Share

  42. SU GL, Altayar O, O'Shea R, Shah R, et al
    AGA Clinical Practice Guideline on Systemic Therapy for Hepatocellular Carcinoma.
    Gastroenterology. 2022;162:920-934.
    >> Share

  43. MAYDEO A, Patil G
    How to Approach a Patient With Gastric Varices.
    Gastroenterology. 2022;162:689-695.
    >> Share

    February 2022
  44. CHENG N, Ren Y, Zhou J, Zhang Y, et al
    Deep learning-based classification of hepatocellular nodular lesions on whole-slide histopathologic images.
    Gastroenterology. 2022 Feb 21. pii: S0016-5085(22)00155.
    >> Share

  45. CARRIQUE L, Lynch J, Selzner N
    We thank Bekki et al and Bhagat et al for their comments on our article "Results of Early Transplantation for Alcohol-Related Cirrhosis: Integrated Addiction Treatment with Low Rate of Relapse". Bekki et al pointed out a trend toward inferior graft su
    Gastroenterology. 2022 Feb 3. pii: S0016-5085(22)00103.
    >> Share

  46. STRAZZABOSCO M, Cabibbo G, Colombo M
    Adjusting BCLC staging system to the evolving landscape of Hepatocellular Carcinoma. A look to the future.
    Gastroenterology. 2022 Feb 2. pii: S0016-5085(22)00090.
    >> Share

  47. KANNEGANTI M, Singal AG
    Gastroenterology. 2022 Feb 1. pii: S0016-5085(22)00092.
    >> Share

  48. LEE SK, Wong JC, Ng JJ
    An Uncommon Cause of Hematemesis in a Patient With End-stage Renal Disease.
    Gastroenterology. 2022;162:404-405.
    >> Share

  49. TAI Y, Wang Z, Wu H
    An Unusual Cause of Isolated Gastric Varices.
    Gastroenterology. 2022;162:e4-e6.
    >> Share

  50. QU C, Wang HY, Xiu DR
    A Rare Liver Tumor Nodule.
    Gastroenterology. 2022;162:e1-e3.
    >> Share

    January 2022
  51. WILLIAMS R, White PM, Balzora S
    "A T.E.A.M. Approach to Diversity, Equity and Inclusion in Gastroenterology and Hepatology".
    Gastroenterology. 2022 Jan 21. pii: S0016-5085(22)00035.
    >> Share

  52. WILSON SR, Duncan AW
    Single-Cell DNA Sequencing Reveals Chromosomal Diversity in HCC and a Novel Model of HCC Evolution.
    Gastroenterology. 2022;162:46-48.
    >> Share

    December 2021
  53. YANG AH, Gandhi S, Urrunaga NH
    Liver Tumor post Liver Transplantation for Hepatitis C Cirrhosis: An Unusual Cause.
    Gastroenterology. 2021 Dec 26. pii: S0016-5085(21)04161.
    >> Share

  54. FORNER A, Colombo M
    The maze of systemic therapy for hepatocellular carcinoma: did we find the compass?
    Gastroenterology. 2021 Dec 23. pii: S0016-5085(21)04121.
    >> Share

    Gastroenterology. 2021 Dec 1. pii: S0016-5085(21)03811.
    >> Share

  56. GERMAN MN, Brown R, Lucey MR
    Out With the Old, in With the New: Replacing the "6-Month Abstinence Rule" With Integrated Care for Alcohol-Associated Liver Disease.
    Gastroenterology. 2021;161:1795-1797.
    >> Share

  57. POLLO-FLORES P, Trebicka J
    Statins After Variceal Bleeding Are Beneficial, but Still an Unexplained Mystery?
    Gastroenterology. 2021;161:2067-2068.
    >> Share

  58. BARRITT AS 4TH, Moon AM
    Bariatric Surgery and Cancer Risk in Nonalcoholic Fatty Liver Disease-Effective Intervention for a Select Few.
    Gastroenterology. 2021;161:2063-2064.
    >> Share

  59. RAMAI D, Facciorusso A
    Liver Cancer Reduction After Bariatric Surgery: Time to Expand Its Indication?
    Gastroenterology. 2021;161:2063.
    >> Share

  60. KIM WR, Mannalithara A, Heimbach JK, Kamath PS, et al
    MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
    Gastroenterology. 2021;161:1887-1895.
    >> Share

  61. SACK JS, Patel RS, Ahmad J
    Nausea and Vomiting 8 Months After Liver Transplantation.
    Gastroenterology. 2021;161:e12-e14.
    >> Share

    November 2021
  62. LOOMBA R, Ratziu V, Harrison SA
    Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis.
    Gastroenterology. 2021 Nov 22. pii: S0016-5085(21)03795.
    >> Share

  63. BHAGAT N, Rathi S, Singh V
    Early Transplantation for Alcohol-Related Cirrhosis: Risks, Resources, and Relapse.
    Gastroenterology. 2021 Nov 5. pii: S0016-5085(21)03724.
    >> Share

  64. KANWAL F, Shubrook JH, Adams LA, Pfotenhauer K, et al
    Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2021;161:1657-1669.
    >> Share

  65. WANG X, Cheng Z
    Nodules on the Lower Legs With Ankle Joint Pain.
    Gastroenterology. 2021;161:1390-1392.
    >> Share

  66. VARGAS JF, Arab JP
    Pulsatile Epigastric Mass and Liver Masses in a 38-Year-Old Patient With Splenomegaly Since Childhood.
    Gastroenterology. 2021;161:e14-e16.
    >> Share

    October 2021
  67. LEE TH, Roper J, King L
    Gastroenterology. 2021 Oct 21. pii: S0016-5085(21)03662.
    >> Share

  68. LIU N, Chang CW, Steer CJ, Wang XW, et al
    MicroRNA-15a/16-1 Prevents Hepatocellular Carcinoma by Disrupting the Communication between Kupffer Cells and Tregs.
    Gastroenterology. 2021 Oct 19. pii: S0016-5085(21)03652.
    >> Share

  69. PEERY AF, Crockett SD, Murphy CC, Jensen ET, et al
    Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021.
    Gastroenterology. 2021 Oct 19. pii: S0016-5085(21)03655.
    >> Share

  70. LOUISSAINT J, Gibbs JT, Lok AS, Tapper EB, et al
    Strategies to Improve Video Visit Use in Persons With Liver Disease.
    Gastroenterology. 2021;161:1080-1084.
    >> Share

    September 2021
  71. INTAGLIATA NM, Davitkov P, Allen AM, Falck-Ytter YT, et al
    AGA Technical Review on Coagulation in Cirrhosis.
    Gastroenterology. 2021 Sep 24. pii: S0016-5085(21)03477.
    >> Share

  72. O'SHEA RS, Davitkov P, Ko CW, Rajasekhar A, et al
    AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis.
    Gastroenterology. 2021 Sep 24. pii: S0016-5085(21)03382.
    >> Share

  73. DREYER SB, Upstill-Goddard R, Legrini A, Biankin AV, et al
    Genomic and molecular analyses identify molecular subtypes of pancreatic cancer recurrence.
    Gastroenterology. 2021 Sep 14. pii: S0016-5085(21)03522.
    >> Share

  74. BEKKI Y, Fenig Y
    Evaluation of Early Liver Transplantation for Alcohol-Related Cirrhosis.
    Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03491.
    >> Share

  75. SHAH BJ, Onken JE, Edgar L, Jou JH, et al
    Development of Gastroenterology and Transplant Hepatology Milestones 2.0: A Guide for Programs, Faculty, and Fellows.
    Gastroenterology. 2021 Sep 3. pii: S0016-5085(21)03335.
    >> Share

  76. GUO L, Yi X, Chen L, Zhang T, et al
    Single cell DNA sequencing reveals punctuated and gradual clonal evolution in hepatocellular carcinoma.
    Gastroenterology. 2021 Sep 2. pii: S0016-5085(21)03471.
    >> Share

  77. KANWAL F, Shubrook JH, Younossi Z, Natarajan Y, et al
    Preparing for the NASH Epidemic: A Call to Action.
    Gastroenterology. 2021;161:1030-1042.
    >> Share

  78. HABER PK, Puigvehi M, Castet F, Lourdusamy V, et al
    Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002-2020).
    Gastroenterology. 2021;161:879-898.
    >> Share

    A Visual Engram Worth Remembering.
    Gastroenterology. 2021;161:809-810.
    >> Share

  80. FUCHS A, Samovski D, Smith GI, Cifarelli V, et al
    Associations Among Adipose Tissue Immunology, Inflammation, Exosomes and Insulin Sensitivity in People With Obesity and Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2021;161:968-981.
    >> Share

    August 2021
  81. BALZORA S, May FP, Ogedegbe G
    COVID-19 and Social Determinants of Health in Gastroenterology and Hepatology.
    Gastroenterology. 2021 Aug 26. pii: S0016-5085(21)03438.
    >> Share

  82. SU F
    COVID-19 and cirrhosis: a combination we must strive to prevent.
    Gastroenterology. 2021 Aug 25. pii: S0016-5085(21)03417.
    >> Share

  83. AZZIMATO V, Chen P, Barreby E, Morgantini C, et al
    Hepatic miR-144 drives fumarase activity preventing NRF2 activation during obesity.
    Gastroenterology. 2021 Aug 20. pii: S0016-5085(21)03410.
    >> Share

  84. OLYNYK JK, Ramm GA
    Gastroenterology. 2021 Aug 19. pii: S0016-5085(21)03405.
    >> Share

  85. TAI CS, Ni YH, Lee PI
    An Unusual Case with a Huge Hepatic Cystic Mass.
    Gastroenterology. 2021 Aug 12. pii: S0016-5085(21)03357.
    >> Share

  86. CARRIQUE L, Quance J, Tan A, Abbey S, et al
    Results of Early Transplantation for Alcohol-Related Cirrhosis: Integrated Addiction Treatment with Low Rate of Relapse.
    Gastroenterology. 2021 Aug 6. pii: S0016-5085(21)03342.
    >> Share

  87. GOUGH NR, Xiang X, Mishra L
    TGF-beta Signaling in Liver, Pancreas, and Gastrointestinal Diseases and Cancer.
    Gastroenterology. 2021;161:434-452.
    >> Share

    July 2021
  88. MEHTA N, Frenette C, Tabrizian P, Hoteit M, et al
    Down-staging Outcomes for Hepatocellular Carcinoma: Results from the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium.
    Gastroenterology. 2021 Jul 28. pii: S0016-5085(21)03284.
    >> Share

  89. LOOMBA R, Mohseni R, Lucas KJ, Gutierrez JA, et al
    TVB-2640 (FASN inhibitor) for the treatment of nonalcoholic steatohepatitis: FASCINATE-1, a randomized, placebo-controlled Ph2a trial.
    Gastroenterology. 2021 Jul 20. pii: S0016-5085(21)03276.
    >> Share

  90. GE J, Pletcher MJ, Lai JC
    Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study.
    Gastroenterology. 2021 Jul 17. pii: S0016-5085(21)03244.
    >> Share

  91. YE P, Miao H, Chen Y
    An unusual case of symptomatic portal hypertension.
    Gastroenterology. 2021 Jul 16. pii: S0016-5085(21)03253.
    >> Share

  92. MAAN R, Darwish Murad S, van der Meer AJ
    Letter to the Editor: Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: A Meta-analysis of Individual Patient Data.
    Gastroenterology. 2021;161:371-372.
    >> Share

  93. LI L, Liu C, Qi X
    Letter to the Editor: Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: A Meta-analysis of Individual Patient Data.
    Gastroenterology. 2021;161:370-371.
    >> Share

  94. PARIKH ND, Chung GS, Mellinger J, Blanchette JG, et al
    Alcohol Policies and Alcohol-related Liver Disease Mortality.
    Gastroenterology. 2021;161:350-352.
    >> Share

  95. RUSTGI VK, Li Y, Gupta K, Minacapelli CD, et al
    Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity.
    Gastroenterology. 2021;161:171-184.
    >> Share

  96. SURAPANENI PK, Mills K, Renelus BD
    A Rare Complication of Sickle Cell Anemia.
    Gastroenterology. 2021;161:45-46.
    >> Share

    June 2021
  97. CHIANG HC, Chien SC, Lin YJ
    Pleural effusion with gastric ulcer.
    Gastroenterology. 2021 Jun 26. pii: S0016-5085(21)03176.
    >> Share

  98. TSOI AH, Garg M, Tsoi EH
    Peptic ulcer disease: an unusual presentation of a common problem.
    Gastroenterology. 2021 Jun 26. pii: S0016-5085(21)03174.
    >> Share

  99. VALENTI L, Mondelli M, Colombo M
    Liver field during immunotherapy of hepatocellular carcinoma: some like it hot.
    Gastroenterology. 2021 Jun 24. pii: S0016-5085(21)03165.
    >> Share

  100. LI H, Liu H
    Recurrent Epistaxis and Diffuse Hepatic and Splenic Vascular Malformations.
    Gastroenterology. 2021 Jun 8. pii: S0016-5085(21)03091.
    >> Share

  101. MEDICI V
    Expanding the Diagnostic Toolkit of Wilson Disease with ATP7B Peptides.
    Gastroenterology. 2021;160:2249-2251.
    >> Share

  102. SU P, Hong J, Li T
    An Uncommon Lesion of the Liver.
    Gastroenterology. 2021;160:2258-2260.
    >> Share

  103. COLLINS CJ, Yi F, Dayuha R, Duong P, et al
    Direct Measurement of ATP7B Peptides Is Highly Effective in the Diagnosis of Wilson Disease.
    Gastroenterology. 2021;160:2367-2382.
    >> Share

    May 2021
  104. EDWARDS LA, Goldenberg SD, Shawcross DL
    Meeting the challenge of antimicrobial resistance in cirrhosis: the invisible threat that lies within.
    Gastroenterology. 2021 May 25. pii: S0016-5085(21)03065.
    >> Share

  105. GARCIA-TSAO G, Abraldes JG
    Non-selective beta-blockers in compensated cirrhosis: Preventing variceal hemorrhage or preventing decompensation?
    Gastroenterology. 2021 May 11. pii: S0016-5085(21)02972.
    >> Share

  106. PERRY IE, Azam MU, Yap JE
    Carcinoma Camouflage.
    Gastroenterology. 2021;160:1940-1942.
    >> Share

  107. SHEN C, Zong Z, Xu N
    "Malignant" Liver Cysts Cause Liver Failure and Recurrence.
    Gastroenterology. 2021;160:e7-e9.
    >> Share

  108. NAYAK LJ, Sondhi AR, Westerhoff M
    Gastroenterology. 2021;160:e5-e6.
    >> Share

  109. HA NB, Wang CW, El-Nachef N
    An Unusual Mechanical Cause of Upper Gastrointestinal Hemorrhage.
    Gastroenterology. 2021;160:e1-e4.
    >> Share

    April 2021
  110. PACK M
    Model Organisms Help Define the ABCs of Neonatal Cholestasis.
    Gastroenterology. 2021 Apr 15. pii: S0016-5085(21)00636.
    >> Share

  111. SHAMSADDINI A, Gillevet PM, Acharya C, Fagan A, et al
    Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients with Cirrhosis.
    Gastroenterology. 2021 Apr 12. pii: S0016-5085(21)00634.
    >> Share

  112. SHEEHAN JL, Brandler J, Rice MD
    A Case of Recurrent Hepatic Abscesses.
    Gastroenterology. 2021 Apr 8. pii: S0016-5085(21)00627.
    >> Share

  113. PONZIANI FR, Nesci A, Del Zompo F, Santopaolo F, et al
    Correlation Between Liver Function Tests Abnormalities and Interleukin-6 Serum Levels in Patients With SARS-CoV-2 Infection.
    Gastroenterology. 2021;160:1891-1893.
    >> Share

  114. KHAN MU, Mushtaq K, Alkaabi SR
    Acute-on-Chronic Liver Failure: Possibly the Main Culprit of Increased Mortality in COVID-19 Patients with Liver Disease.
    Gastroenterology. 2021;160:1894-1895.
    >> Share

  115. VERMA N, Duseja A, Singh V
    Impact of Preexisting Chronic Liver Disease on the Outcome of Patients With COVID-19 Disease.
    Gastroenterology. 2021;160:1893-1894.
    >> Share

  116. LUUKKONEN PK, Salomaa V, Aberg F
    The Pi *MZ Allele in Alpha-1 Antitrypsin Increases Liver-Related Outcomes in a Population-Based Study.
    Gastroenterology. 2021;160:1874-1875.
    >> Share

  117. JAMIALAHMADI O, Mancina RM, Ciociola E, Tavaglione F, et al
    Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease.
    Gastroenterology. 2021;160:1634-1646.
    >> Share

    March 2021
  118. PHAM DH, Kudira R, Xu L, Valencia CA, et al
    Deleterious variants in ABCC12 are detected in idiopathic chronic cholestasis and cause intrahepatic bile duct loss in model organisms: ABCC12 pathogenic variants lead to cholestasis.
    Gastroenterology. 2021 Mar 18. pii: S0016-5085(21)00535.
    >> Share

  119. LEE-ALLEN J, Shah BJ
    How to incorporate health equity training into Gastroenterology and Hepatology fellowship.
    Gastroenterology. 2021 Mar 15. pii: S0016-5085(21)00526.
    >> Share

  120. SINGAL AG, Hoshida Y, Pinato DJ, Marrero J, et al
    International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma.
    Gastroenterology. 2021 Mar 8. pii: S0016-5085(21)00518.
    >> Share

  121. ASSELTA R, Paraboschi EM, Gerussi A, Cordell HJ, et al
    X chromosome contribution to the genetic architecture of primary biliary cholangitis.
    Gastroenterology. 2021 Mar 3. pii: S0016-5085(21)00466.
    >> Share

  122. ADENIJI N, Carr RM, Aby ES, Catana AM, et al
    Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Minorities With Chronic Liver Diseases.
    Gastroenterology. 2021;160:1406-1409.
    >> Share

  123. CASADEI-GARDINI A, Cascinu S, Colombo M
    Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma: Ready for Prime Time?
    Gastroenterology. 2021;160:1423-1424.
    >> Share

  124. GOLDBERG D, Ross-Driscoll K, Lynch R
    County Differences in Liver Mortality in the United States: Impact of Sociodemographics, Disease Risk Factors, and Access to Care.
    Gastroenterology. 2021;160:1140-1150.
    >> Share

  125. KOBAYASHI H, Gieniec KA, Wright JA, Wang T, et al
    The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis.
    Gastroenterology. 2021;160:1224-1239.
    >> Share

  126. PRZYBYSZEWSKI EM, Deshpande V, Uchida AM
    An Unsuspected Cause of Rectal Bleeding.
    Gastroenterology. 2021;160:e1-e2.
    >> Share

    February 2021
  127. LIU D, Wong CC, Zhou Y, Li C, et al
    Squalene epoxidase induces nonalcoholic steatohepatitis via binding to carbonic anhydrase 3 and is a therapeutic target.
    Gastroenterology. 2021 Feb 26. pii: S0016-5085(21)00456.
    >> Share

  128. DUWAERTS CC, Le Guillou D, Her CL, Phillips NJ, et al
    iPSC-derived hepatocytes from patients with nonalcoholic fatty liver disease display a disease-specific gene expression profile.
    Gastroenterology. 2021 Feb 25. pii: S0016-5085(21)00455.
    >> Share

    Multiple Hepatic and Pulmonary Tumours Combined with Bilateral Adrenal Masses in a Young Female with von Hippel-Lindau Disease.
    Gastroenterology. 2021 Feb 18. pii: S0016-5085(21)00421.
    >> Share

  130. YOUNOSSI ZM, Corey KE, Lim JK
    AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review.
    Gastroenterology. 2021;160:912-918.
    >> Share

  131. SHINOZAWA T, Kimura M, Cai Y, Saiki N, et al
    High-Fidelity Drug-Induced Liver Injury Screen Using Human Pluripotent Stem Cell-Derived Organoids.
    Gastroenterology. 2021;160:831-846.
    >> Share

  132. NASSANI N, Melitas C, Villa E
    An Unusual Cause of Watery Diarrhea.
    Gastroenterology. 2021;160:671-674.
    >> Share

    January 2021
  133. LISA B VANWAGNER B, Issaka RB
    REPLY: Joseph Ahn, John I Allen, and Vijay H Shah Response to: The Path to Gastroenterology and Hepatology Leadership Inadvertently Perpetuating the Glass Ceiling and Sticky Floor.
    Gastroenterology. 2021 Jan 20. pii: S0016-5085(21)00271.
    >> Share

  134. XU J, Kausalya PJ, Van Hul N, Caldez MJ, et al
    Protective functions of ZO-2/Tjp2 expressed in hepatocytes and cholangiocytes against liver injury and cholestasis.
    Gastroenterology. 2021 Jan 16. pii: S0016-5085(21)00094.
    >> Share

  135. CORLEY DA, Peek RM Jr, Simpson BA
    Paradigm-Shifting Research in Gastroenterology, Hepatology, and Nutrition: A Top 20 List of Articles Published in 2020.
    Gastroenterology. 2021 Jan 14. pii: S0016-5085(21)00087.
    >> Share

  136. MAHMUD N, Kaplan DE, Goldberg DS, Taddei TH, et al
    Changes in Hepatocellular Carcinoma Surveillance and Risk Factors for Non-Completion in the VHA Cohort During the COVID-19 Pandemic.
    Gastroenterology. 2021 Jan 9. pii: S0016-5085(21)00066.
    >> Share

  137. ACHARYA C, Bajaj JS
    Chronic Liver Diseases and the Microbiome-Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease.
    Gastroenterology. 2021;160:556-572.
    >> Share

  138. NICOARA-FARCAU O, Han G, Rudler M, Angrisani D, et al
    Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data.
    Gastroenterology. 2021;160:193-205.
    >> Share

    December 2020
  139. VANWAGNER LB, Issaka RB
    The Path to Gastroenterology & Hepatology Leadership: Inadvertently Perpetuating the Glass Ceiling and Sticky Floor.
    Gastroenterology. 2020 Dec 30. pii: S0016-5085(20)35610.
    >> Share

  140. JIN B, Wu XA, Du SD
    Human Pluripotent Stem Cell-derived Hepatic Organoids: A Promising Novel Model of Liver Diseases.
    Gastroenterology. 2020 Dec 29. pii: S0016-5085(20)35595.
    >> Share

  141. MYOJIN Y, Hikita H, Sugiyama M, Sasaki Y, et al
    Hepatic stellate cells in hepatocellular carcinoma promote tumor growth via growth differentiation factor 15 production.
    Gastroenterology. 2020 Dec 17. pii: S0016-5085(20)35551.
    >> Share

  142. VAN DIJK M, Weehuizen TAF, Lowenberg M
    A rare cause of acute abdominal pain after endoscopic retrograde cholangiopancreaticography.
    Gastroenterology. 2020 Dec 17. pii: S0016-5085(20)35559.
    >> Share

  143. EMDIN CA, Haas M, Ajmera V, Simon TG, et al
    Association of genetic variation with cirrhosis: a multi-trait genome-wide association and gene-environment interaction study.
    Gastroenterology. 2020 Dec 10. pii: S0016-5085(20)35545.
    >> Share

  144. YOUNOSSI ZM, Anstee QM, Wai-Sun Wong V, Trauner M, et al
    The Association of Histologic and Non-invasive Tests with Adverse Clinical and Patient-Reported Outcomes in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis (NASH).
    Gastroenterology. 2020 Dec 8. pii: S0016-5085(20)35529.
    >> Share

  145. ARVIND A, Osganian SA, Sjoquist JA, Corey KE, et al
    Epoxygenase-Derived Epoxyeicosatrienoic Acid Mediators Are Associated With Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Fibrosis.
    Gastroenterology. 2020;159:2232-2234.
    >> Share

    November 2020
  146. HSU SJ, Zhang C, Jeong J, Lee SI, et al
    Enhanced meningeal lymphatic drainage ameliorates neuroinflammation and hepatic encephalopathy in cirrhotic rats.
    Gastroenterology. 2020 Nov 20. pii: S0016-5085(20)35439.
    >> Share

  147. LAU LHS, Wong SH, Yip TCF, Wong GLH, et al
    Collateral Effect of Coronavirus Disease 2019 Pandemic on Hospitalizations and Clinical Outcomes in Gastrointestinal and Liver Diseases: A Territory-wide Observational Study in Hong Kong.
    Gastroenterology. 2020;159:1979-1981.
    >> Share

  148. NOUREDDIN M, Jones C, Alkhouri N, Gomez EV, et al
    Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis.
    Gastroenterology. 2020;159:1985-1987.
    >> Share

  149. XANTHAKOS SA, Lavine JE, Yates KP, Schwimmer JB, et al
    Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice.
    Gastroenterology. 2020;159:1731-1751.
    >> Share

  150. LANG S, Demir M, Martin A, Jiang L, et al
    Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2020;159:1839-1852.
    >> Share

    October 2020
  151. VERBOVEN E, Moya IM, Sansores-Garcia L, Xie J, et al
    Regeneration Defects in Yap and Taz Mutant Mouse Livers are Caused by Bile Duct Disruption and Cholestasis.
    Gastroenterology. 2020 Oct 27. pii: S0016-5085(20)35324.
    >> Share

  152. DOUGAN M, Wang Y, Rubio-Tapia A, Lim JK, et al
    AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor (ICI) Colitis and Hepatitis: Expert Review.
    Gastroenterology. 2020 Oct 17. pii: S0016-5085(20)35282.
    >> Share

  153. ASEEM SO, Jalan-Sakrikar N, Chi C, Navarro-Corcuera A, et al
    Epigenomic Evaluation of Cholangiocyte TGFbeta Signaling Identifies a Selective Role for Histone 3 Lysine 9 Acetylation in Biliary Fibrosis.
    Gastroenterology. 2020 Oct 12. pii: S0016-5085(20)35245.
    >> Share

  154. DE VRIES E, Bolier R, Goet J, Pares A, et al
    Fibrates for itch (FITCH) in fibrosing cholangiopathies: a double blind, randomized, placebo-controlled trial.
    Gastroenterology. 2020 Oct 5. pii: S0016-5085(20)35226.
    >> Share

  155. ROMEO S
    MARC1 and HNRNPUL1: Two Novel Players in Alcohol-related Liver Disease.
    Gastroenterology. 2020;159:1231-1232.
    >> Share

  156. RAMLI MNB, Lim YS, Koe CT, Demircioglu D, et al
    Human Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease.
    Gastroenterology. 2020;159:1471-1486.
    >> Share

    September 2020
  157. HEINRICH B, Brown ZJ, Diggs LP, Vormehr M, et al
    Steatohepatitis Impairs T cell-directed Immunotherapies Against Liver Tumors in Mice.
    Gastroenterology. 2020 Sep 30. pii: S0016-5085(20)35212.
    >> Share

  158. ROGAL SS, Powell BJ, Chinman M
    Moving towardsImpact: An Introduction to Implementation Science for Gastroenterologists and Hepatologists.
    Gastroenterology. 2020 Sep 17. pii: S0016-5085(20)35166.
    >> Share

  159. SOLE C, Guilly S, Da Silva K, Llopis M, et al
    Gastroenterology. 2020 Sep 14. pii: S0016-5085(20)35150.
    >> Share

  160. GUIDOTTI LG, La Vecchia C, Colombo M
    Is it time to recommend low-dose aspirin treatment for the prevention of hepatocellular carcinoma?
    Gastroenterology. 2020 Sep 9. pii: S0016-5085(20)35134.
    >> Share

  161. VILAR-GOMEZ E, Sookoian S, Pirola CJ, Liang T, et al
    ADH1B *2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption.
    Gastroenterology. 2020;159:929-943.
    >> Share

  162. CHAI C, Cox B, Yaish D, Gross D, et al
    Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
    Gastroenterology. 2020;159:999-1014.
    >> Share

  163. WANG Y, Pan Y, Zhou Z
    An Unusual Cause of Fever in a Man With a Liver Mass.
    Gastroenterology. 2020;159:842-844.
    >> Share

    August 2020
  164. MOLINA-SANCHEZ P, Ruiz de Galarreta M, Yao MA, Lindblad KE, et al
    Cooperation between distinct cancer driver genes underlies inter-tumor heterogeneity in hepatocellular carcinoma.
    Gastroenterology. 2020 Aug 16. pii: S0016-5085(20)35054.
    >> Share

  165. HARRISON SA, Neff G, Guy CD, Bashir MR, et al
    Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis.
    Gastroenterology. 2020 Aug 8. pii: S0016-5085(20)35018.
    >> Share

  166. FLEMMING JA, Mullin M, Lu J, Sarkar MA, et al
    Outcomes of Pregnant Women With Cirrhosis and Their Infants in a Population-Based Study.
    Gastroenterology. 2020 Aug 8. pii: S0016-5085(20)35024.
    >> Share

  167. JANSSON-KNODELL CL, Walker MJ, Fischer M
    Pancytopenia in a Young Male Patient with Inflammatory Bowel Disease.
    Gastroenterology. 2020 Aug 7. pii: S0016-5085(20)35027.
    >> Share

  168. SINGH S, Khan A
    Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Among Patients With Preexisting Liver Disease in the United States: A Multicenter Research Network Study.
    Gastroenterology. 2020;159:768-771.
    >> Share

  169. PENG H, Fu YX
    The Inhibitory PVRL1/PVR/TIGIT Axis in Immune Therapy for Hepatocellular Carcinoma.
    Gastroenterology. 2020;159:434-436.
    >> Share

  170. ZOLLER H, Wagner S, Tilg H
    Is Heterozygosity for the Alpha-1 Antitrypsin Risk Allele Pi *MZ a Disease Modifier or Genetic Risk Factor?
    Gastroenterology. 2020;159:433-434.
    >> Share

  171. NABI O, Lacombe K, Boursier J, Mathurin P, et al
    Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in General Population: the French Nationwide NASH-CO Study.
    Gastroenterology. 2020;159:791-793.
    >> Share

  172. SCHNEIDER CV, Hamesch K, Gross A, Mandorfer M, et al
    Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi *Z Variant of AAT (Pi *MZ vs Pi *ZZ genotype) and Noncarriers.
    Gastroenterology. 2020;159:534-548.
    >> Share

  173. GUPTA V, Gupta I, Park J, Bram Y, et al
    Hedgehog Signaling Demarcates a Niche of Fibrogenic Peribiliary Mesenchymal Cells.
    Gastroenterology. 2020;159:624-638.
    >> Share

  174. NAUDIN CR, Maner-Smith K, Owens JA, Wynn GM, et al
    Lactococcus lactis Subspecies cremoris Elicits Protection Against Metabolic Changes Induced by a Western-Style Diet.
    Gastroenterology. 2020;159:639-651.
    >> Share

    July 2020
  175. BAJAJ JS, Reddy KR, O'Leary JG, Vargas HE, et al
    Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute on Chronic Liver Failure and Death in Patients With Cirrhosis.
    Gastroenterology. 2020 Jul 17. pii: S0016-5085(20)34947.
    >> Share

  176. SULTAN S, Altayar O, Siddique SM, Davitkov P, et al
    AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19.
    Gastroenterology. 2020;159:320-334.
    >> Share

  177. ARNOLD M, Abnet CC, Neale RE, Vignat J, et al
    Global Burden of 5 Major Types of Gastrointestinal Cancer.
    Gastroenterology. 2020;159:335-349.
    >> Share

  178. KOTHA S, Potts J, Thorburn D
    An Unusual Complication of a Cystic Liver Lesion.
    Gastroenterology. 2020;159:e9-e11.
    >> Share

    June 2020
  179. SKARET MM, Vicente DA, Deising AC
    An Enlarging Hepatic Mass of Unknown Etiology.
    Gastroenterology. 2020 Jun 26. pii: S0016-5085(20)34858.
    >> Share

  180. DASGUPTA D, Nakao Y, Mauer AS, Thompson JM, et al
    IRE1A Stimulates Hepatocyte-derived Extracellular Vesicles That Promote Inflammation in Mice With Steatohepatitis.
    Gastroenterology. 2020 Jun 20. pii: S0016-5085(20)34831.
    >> Share

  181. LA VECCHIA C, Lotti M, Colombo M
    Asbestos exposure and increased risk of intrahepatic cholangiocarcinoma: enough to infer causality?
    Gastroenterology. 2020 Jun 19. pii: S0016-5085(20)34837.
    >> Share

  182. CHOPYK DM, Grakoui A
    Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.
    Gastroenterology. 2020 Jun 19. pii: S0016-5085(20)34839.
    >> Share

  183. INNES H, Buch S, Hutchinson S, Guha IN, et al
    Genome-wide Association Study for Alcohol-related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1.
    Gastroenterology. 2020 Jun 16. pii: S0016-5085(20)34767.
    >> Share

  184. LASSAILLY G, Caiazzo R, Ntandja-Wandji LC, Gnemmi V, et al
    Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis.
    Gastroenterology. 2020 Jun 15. pii: S0016-5085(20)34758.
    >> Share

  185. RUETHER DF, Menz A, Manthey CF
    A Dishevelled Man with Inflammatory Bowel Disease and Signs of Infection.
    Gastroenterology. 2020 Jun 5. pii: S0016-5085(20)34749.
    >> Share

  186. YIP TC, Wong GL
    Gastroenterology. 2020;158:2312-2313.
    >> Share

  187. ZHAO M, Zhao L, Xiong X, He Y, et al
    TMAVA, a Metabolite of Intestinal Microbes, Is Increased in Plasma From Patients With Liver Steatosis, Inhibits gamma-Butyrobetaine Hydroxylase, and Exacerbates Fatty Liver in Mice.
    Gastroenterology. 2020;158:2266-2281.
    >> Share

    May 2020
  188. DING X, He M, Chan AWH, Song QX, et al
    Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
    Gastroenterology. 2020 May 16. pii: S0016-5085(20)30659.
    >> Share

  189. HAJIFATHALIAN K, Krisko T, Mehta A, Kumar S, et al
    Gastrointestinal and Hepatic Manifestations of 2019 Novel Coronavirus Disease in a Large Cohort of Infected Patients From New York: Clinical Implications.
    Gastroenterology. 2020 May 7. pii: S0016-5085(20)30602.
    >> Share

  190. KIM D, Konyn P, Cholankeril G, Wong RJ, et al
    Decline in Annual Mortality of Hepatitis C Virus-related Hepatocellular Carcinoma in the United States, From 2009 to 2018.
    Gastroenterology. 2020 May 7. pii: S0016-5085(20)30599.
    >> Share

  191. SANGHA M, Kelly CR, Rauschert L
    Liver and Gallbladder Herniation.
    Gastroenterology. 2020 May 7. pii: S0016-5085(20)30279.
    >> Share

  192. MAHMUD N, Hubbard RA, Kaplan DE, Serper M, et al
    Declining Cirrhosis Hospitalizations in the Wake of the COVID-19 Pandemic: A National Cohort Study.
    Gastroenterology. 2020 May 5. pii: S0016-5085(20)30597.
    >> Share

  193. TURATI F, La Vecchia C, Colombo M
    Clinical and Genetic Markers of Nonalcoholic Fatty Liver Disease and Prediction of Liver Disease Mortality: Ready for Population Screening?
    Gastroenterology. 2020;158:1838-1840.
    >> Share

  194. TAYLOR RS, Taylor RJ, Bayliss S, Hagstrom H, et al
    Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Gastroenterology. 2020;158:1611-1625.
    >> Share

  195. SCORLETTI E, Afolabi PR, Miles EA, Smith DE, et al
    Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2020;158:1597-1610.
    >> Share

  196. QIN WH, Yang ZS, Li M, Chen Y, et al
    High Serum Levels of Cholesterol Increase Antitumor Functions of Nature Killer Cells and Reduce Growth of Liver Tumors in Mice.
    Gastroenterology. 2020;158:1713-1727.
    >> Share

  197. MAHER JJ, Schattenberg JM
    Nonalcoholic Fatty Liver Disease in 2020.
    Gastroenterology. 2020;158:1849-1850.
    >> Share

  198. GOLDNER D, Lavine JE
    Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges.
    Gastroenterology. 2020;158:1967-1983.
    >> Share

  199. KRAWCZYK M, Liebe R, Lammert F
    Toward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond.
    Gastroenterology. 2020;158:1865-1880.
    >> Share

  200. AZZU V, Vacca M, Virtue S, Allison M, et al
    Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2020;158:1899-1912.
    >> Share

  201. SARAN AR, Dave S, Zarrinpar A
    Circadian Rhythms in the Pathogenesis and Treatment of Fatty Liver Disease.
    Gastroenterology. 2020;158:1948-1966.
    >> Share

    Therapeutic Landscape for NAFLD in 2020.
    Gastroenterology. 2020;158:1984-1998.
    >> Share

  203. COTTER TG, Rinella M
    Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.
    Gastroenterology. 2020;158:1851-1864.
    >> Share

  204. ARON-WISNEWSKY J, Warmbrunn MV, Nieuwdorp M, Clement K, et al
    Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
    Gastroenterology. 2020;158:1881-1898.
    >> Share

  205. SCHWABE RF, Tabas I, Pajvani UB
    Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis.
    Gastroenterology. 2020;158:1913-1928.
    >> Share

  206. ESLAM M, Sanyal AJ, George J
    MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.
    Gastroenterology. 2020;158:1999-2014.
    >> Share

    April 2020
  207. NOUREDDIN M, Chan JL, Barradas K, Dimick-Santos L, et al
    Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations from the Multi-stakeholder Liver Forum.
    Gastroenterology. 2020 Apr 27. pii: S0016-5085(20)30556.
    >> Share

  208. PONTES AFECTO EM, Joao DA, Resende Rodrigues MA
    Unusual esophageal polyps in advanced cirrhosis.
    Gastroenterology. 2020 Apr 23. pii: S0016-5085(20)30559.
    >> Share

  209. GOTFRIED J, Naftali T, Schey R
    Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease.
    Gastroenterology. 2020 Apr 22. pii: S0016-5085(20)30563.
    >> Share

  210. KRIETMAN K, Snell PD, Kothadia JP
    An Uncommon Cause of Hepatic Hematoma.
    Gastroenterology. 2020 Apr 17. pii: S0016-5085(20)30508.
    >> Share

  211. CARVAO J, Pereira VM, Jasmins L
    A case of unexplained cutaneous lesions, cholestatic hepatitis and non-cirrhotic portal hypertension in a female patient.
    Gastroenterology. 2020 Apr 16. pii: S0016-5085(20)30494.
    >> Share

  212. KAMBOJ AK, Yung-Lun Chin J, Huebert RC
    A Curious Case of Confusion in a Patient with Cirrhosis.
    Gastroenterology. 2020 Apr 15. pii: S0016-5085(20)30513.
    >> Share

  213. KUNG-CHUN CHIU D, Wai-Hin Yuen V, Wing-Sum Cheu J, Wei LL, et al
    Hepatocellular Carcinoma Cells Upregulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice.
    Gastroenterology. 2020 Apr 7. pii: S0016-5085(20)30461.
    >> Share

  214. THEVENOT T, Charon-Barra C, Calame P
    Unusual Calcified Lesions of the Liver and Lung in a Young Woman.
    Gastroenterology. 2020;158:1222-1223.
    >> Share

  215. ZHANG Y, Shaikh N, Ferey JL, Wankhade UD, et al
    Lactotrehalose, an Analog of Trehalose, Increases Energy Metabolism Without Promoting Clostridioides difficile Infection in Mice.
    Gastroenterology. 2020;158:1402-1416.
    >> Share

    March 2020
  216. EL-SERAG HB, Kanwal F, Feng Z, Marrero JA, et al
    Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings from Texas Hepatocellular Carcinoma Consortium Cohort.
    Gastroenterology. 2020 Mar 29. pii: S0016-5085(20)30403.
    >> Share

    Channelopathy of the pancreas causes chronic pancreatitis.
    Gastroenterology. 2020 Mar 20. pii: S0016-5085(20)30376.
    >> Share

  218. LIU P, Liang B, Liu M, Lebbink JHG, et al
    Oncogenic Mutations in Armadillo Repeats 5 and 6 of beta-Catenin Reduce Binding to APC, Increasing Signaling and Transcription of Target Genes.
    Gastroenterology. 2020;158:1029-1043.
    >> Share

    February 2020
  219. BIECHELE J, Fox M
    A Patient with Metastatic Lung Cancer and Dysphagia.
    Gastroenterology. 2020;158:485-487.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016